CIENCIASMEDICASNEWS: Cancers of the Head & Neck | Home ► Your invitation to submit to Cancers of the Head & Neck

martes, 21 de junio de 2016

Cancers of the Head & Neck | Home ► Your invitation to submit to Cancers of the Head & Neck

Cancers of the Head & Neck | Home

BioMed Central – The Open Access Publisher

Dear Prof CERASALE MORTEO,

We are pleased to announce that Cancers of the Head & Neck has published its first articles with BioMed Central.

Read a Selection of Our First Articles

EDITORIAL

Introducing cancers of the head and neck, a new open access journal

Barbara Burtness

Full text | PDF

REVIEW

Genomic insights into head and neck cancer

Tim N. Beck, Erica A. Golemis

Abstract | Full text | PDF

RESEARCH

Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer

Shrujal Subhash Baxi et al.

Abstract | Full text | PDF

Journal Scope

Cancers of the Head & Neck is an open access, peer-reviewed journal dedicated to publishing articles on pre-clinical and translational research, as well as research related to the clinical management of head and neck cancers. This includes cancers of the oral cavity, pharynx, larynx, paranasal sinuses, nasal cavity and salivary glands. Articles related to the etiology, pathophysiology, prevention, diagnosis, treatment and survivorship of these cancers are all considered.

Reasons to Publish with Us

•	Open access: fostering an active academic exchange through free, permanent online access
•	Supported by a distinguished expert Editorial Board
•	High quality and in-depth peer review

Publish with us

Best wishes,

The BioMed Central Team

Call for papers: Translational oncology

We are pleased to announce that a number of BioMed Central journals have come together to create a new cross-journal series on translational oncology.

Guest Edited by Prof Tommaso Dragani (Fondazione IRCCS Istituto Nazionale dei Tumori, Italy), the series is now accepting submissions of research articles that provide important developments in cancer research. Preclinical studies should provide a significant advance in knowledge, and have clear potential for strong clinical impact.

More information